Home
OrganOx

OrganOx Market Share Analysis for July 2026

OrganOx advances liver transplantation with normothermic perfusion to extend preservation and improve patient outcomes.

Health > Health - Other

Domainorganox.com

Year Founded2008

Employees51 - 200

Annual Revenue$15M - $25M

OrganOx

OrganOx (including company regionals)

organox.com

See more website traffic and engagement information

OrganOx Revenue up to July 2026 is 15M - 25M

revenue generated by OrganOx top domains

OrganOx top domains revenue over 3 years

Revenue for OrganOx top domains

organox.com15M - 25M

See more with Sales Intelligence

Total visits to OrganOx's top domains

Understand OrganOx market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

organox.com8K

See more with Sales Intelligence

Avg. visit duration in OrganOx's top domains

Analyze OrganOx engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

organox.com00:00:53

See more with Sales Intelligence

Avg. pageviews on OrganOx's top domains

See how OrganOx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

organox.com2.90

See more with Sales Intelligence

OrganOx top competitors by domain

Top similar sites in July 2026, ranked by their affinity

xvivogroup.comCompany NameXvivoEmployees51 - 200HQSweden, GothenburgAnnual revenue--Total visits13.8KN/A

Top technologies used by OrganOx

These are the website technologies, by industry, used by OrganOx top domains

Advertising (4)

DoubleClick

Audio Video Media (3)

YouTube

Marketing (3)

Google Marketing Platform

Content Management System (2)

WordPress

More Technologies

11

See all

News & Signals from OrganOx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCraig Marshall left OrganOx Limited as CEO on Jun 2nd '26.Amadeus Capital Partners today announced that Craig Marshall, former CEO of OrganOx, has joined the firm as a Venture Partner, strengthening its support for founders building complex, science-led technology businesses.

NewsDeitsch left OrganOx Limited as Chief Financial Officer on Jul 1st '25.Prior to his current role, Deitsch served as Chief Financial Officer of OrganOx, where he led the company through its 2025 sale to Terumo Corporation in a transaction valued at $1.5 billion.

NewsTerumo Medical Corporation acquired OrganOx Limited for $1.5B on Oct 1st '25.In October 2025, Terumo completed its previously announced acquisition of OrganOx for nearly $1.5bn after meeting all necessary regulatory and closing requirements.